What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Philippe Ruszniewski mainly focuses on Internal medicine, Endocrinology, Pathology, Pancreatic disease and Pancreas.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Multiple endocrine neoplasia.
His work on Somatostatin as part of general Endocrinology research is often related to PRSS2, PRSS1 Gene and Lanreotide, thus linking different fields of science.
His Pathology research incorporates themes from Mucinous cystadenoma and Pancreatitis.
His work deals with themes such as Blood flow, Radiology, Zollinger-Ellison syndrome, Survival rate and Adenocarcinoma, which intersect with Pancreatic disease.
His Pancreas study combines topics in areas such as Cancer research, Malignancy, Molecular pathology, Adenoma and Histopathology.
His most cited work include:
- Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). (404 citations)
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids (295 citations)
- Prognostic factors in patients with endocrine tumours of the duodenopancreatic area (223 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Gastroenterology, Neuroendocrine tumors, Pathology and Pancreas.
The study incorporates disciplines such as Endocrinology, Surgery and Oncology in addition to Internal medicine.
Many of his studies involve connections with topics such as Risk factor and Gastroenterology.
His Neuroendocrine tumors study combines topics from a wide range of disciplines, such as Cancer research, Octreotide and Clinical endpoint.
A large part of his Pathology studies is devoted to Serous Cystadenoma.
His studies examine the connections between Pancreas and genetics, as well as such issues in Radiology, with regards to Pancreatic duct.
He most often published in these fields:
- Internal medicine (53.35%)
- Gastroenterology (26.56%)
- Neuroendocrine tumors (22.25%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (53.35%)
- Neuroendocrine tumors (22.25%)
- Gastroenterology (26.56%)
In recent papers he was focusing on the following fields of study:
Philippe Ruszniewski focuses on Internal medicine, Neuroendocrine tumors, Gastroenterology, In patient and Surgery.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.
Philippe Ruszniewski interconnects Well differentiated, MEN1, Endocrine system and Chemotherapy in the investigation of issues within Oncology.
Neuroendocrine tumors is the subject of his research, which falls under Pathology.
His research in Gastroenterology tackles topics such as Retrospective cohort study which are related to areas like Stage.
His study focuses on the intersection of Surgery and fields such as Pancreatic fistula with connections in the field of Laparoscopy and Single Center.
Between 2014 and 2021, his most popular works were:
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids (295 citations)
- ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. (170 citations)
- Laparoscopic Pancreaticoduodenectomy Should Not Be Routine for Resection of Periampullary Tumors (115 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Philippe Ruszniewski spends much of his time researching Internal medicine, Neuroendocrine tumors, Gastroenterology, Oncology and Surgery.
Philippe Ruszniewski frequently studies issues relating to Endocrinology and Internal medicine.
His work carried out in the field of Neuroendocrine tumors brings together such families of science as Proportional hazards model, MEN1 and Cohort study.
His studies deal with areas such as Etiology, Genetic testing and Hazard ratio as well as Gastroenterology.
He has researched Oncology in several fields, including Ki-67, Pituitary tumors, Expressivity and Endocrine system.
His Pathology research incorporates elements of Confidence interval and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
